Omiya, Japan

Tatsuo Kujirai

This inventor holds 1 USPTO granted patent. Top assignee: Chugai Seiyaku Kabushiki Kaisha. Active years: 1980.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Tatsuo Kujirai. Retrieved from https://idiyas.com/inventor/tatsuo-kujirai

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 24(Granted Patents)


Company Filing History:


Years Active: 1980

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Tatsuo Kujirai

Introduction

Tatsuo Kujirai is a notable inventor based in Ohmiya, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of circulatory diseases. His work has led to the development of innovative compounds that hold promise for medical applications.

Latest Patents

Kujirai holds a patent for a compound known as the nitric ester of N-(2-hydroxyethyl)nicotinamide. This compound is recognized for its potential use in treating circulatory diseases. The formula associated with this patent is ##STR1##, which highlights the chemical structure of the compound.

Career Highlights

Kujirai is affiliated with Chugai Seiyaku Kabushiki Kaisha, a prominent pharmaceutical company in Japan. His role at the company has allowed him to focus on research and development in the pharmaceutical sector, contributing to advancements in medical treatments.

Collaborations

Throughout his career, Kujirai has collaborated with esteemed colleagues such as Hiroyuki Nagano and Takashi Mori. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Tatsuo Kujirai's contributions to the field of pharmaceuticals, particularly through his patent for a compound aimed at treating circulatory diseases, underscore his role as an influential inventor. His work continues to impact the medical community positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…